Dermalex Eczema ‘Breakthrough’ Claim Breaks Down In UK Review
This article was originally published in The Rose Sheet
Executive Summary
Omega Pharma argues its product provides eczema treatment with multiple benefits commonly available only by using separate products – emollients to protect skin from moisture loss and reducing dryness and topical corticosteroids to reduce inflammation and redness.
You may also be interested in...
Omega Pharma's On-Screen Text Fails UK Ad Regulator's Reading Test
The UK Advertising Standards Authority orders Omega Pharma to discontinue an ad for Broncho Stop cough syrup as onscreen text intended to qualify claims was not legible. ASA notes the text met ad guidelines for size, but was compressed and difficult to read.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.